New app puts popular cognitive assessment tool onto smartphones
By
Aaron Dorman
Feb 23, 2024
A new app allows users to take a rapid version of the Montreal Cognitive Assessment on their smartphone, for early warning signs of dementia.
Future of promising Alzheimer’s treatment Leqembi could depend on access to data reporting, analysis:...
By
Aaron Dorman
Feb 16, 2024
Organizations must have clearer guidelines as to how data on lecanemab will be collected, pooled and studied, policy experts say.
AI-aided system can help improve stroke rehab, reduce risk of second emergency, report finds
By
Aaron Dorman
Feb 12, 2024
A new AI model was able to reduce older adults’ recurrent strokes, heart attacks and vascular death, researchers discovered.
Fintech to manage seniors’ finances could be priceless, but only if it steers clear of cyber scam risks,...
By
Aaron Dorman
Feb 08, 2024
New fintech exists to help caregivers assist older adults with finances, but developers have to show those tools won’t compromise their privacy.
Visionary Alzheimer’s forecasting software gets FDA approval
By
Aaron Dorman
Jan 30, 2024
A newly regulated Alzheimer’s software tool offers clarity on whether the condition is likely to progress to dementia in someone with mild cognitive impairment.
‘Adaptive’ brain stimulation tool could improve care for late-stage Parkinson’s seniors
By
Aaron Dorman
Jan 11, 2024
A long-term research study on DBS may have achieved two goals: increasing the area of stimulation and creating a more efficient process.
Ultrasound tech could allow for ultrafast Alzheimer’s treatment, study finds
By
Aaron Dorman
Jan 09, 2024
Researchers have found a way to deliver Alzheimer’s drugs faster via focused ultrasound technology, a new study shows.
As RPM companies create new sensors, new data, senior care industry must catch up, exec says
By
Aaron Dorman
Jan 02, 2024
Although many RPM innovations, such as using AI, are similar across companies, much territory is left to expand, one leader suggests.
Novel deep-brain ‘superfiber’ could mean better Alzheimer’s imaging, diagnoses
By
Aaron Dorman
Dec 04, 2023
A novel “superfiber” could provide imaging of brain tissues in a less invasive way than conventional methods, researchers say.
Brain imaging company teases tech that will analyze side effects of new dementia drugs
By
Aaron Dorman
Nov 28, 2023
AI-enabled brain imaging technology will be launched next year to evaluate the side effects of new Alzheimer’s and dementia drugs.